SUPERNUS PHARMACEUTICALS, INC. Share-based Payment Arrangement, Expense in USD from 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Supernus Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to Q3 2025.
  • Supernus Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $30.7M, a 301% increase year-over-year.
  • Supernus Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $54M, a 103% increase year-over-year.
  • Supernus Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $27.8M, a 3.72% increase from 2023.
  • Supernus Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $26.8M, a 52.3% increase from 2022.
  • Supernus Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $17.6M, a 1.91% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)

SUPERNUS PHARMACEUTICALS, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $54M $30.7M +$23.1M +301% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 $30.9M $7.51M +$955K +14.6% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-05
Q1 2025 $29.9M $8.07M +$2.17M +36.8% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q4 2024 $27.8M $7.63M +$1.19M +18.4% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-25
Q3 2024 $26.6M $7.67M -$246K -3.11% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 $26.8M $6.55M +$464K +7.62% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-05
Q1 2024 $26.4M $5.9M -$409K -6.49% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q4 2023 $26.8M $6.45M +$2.18M +51.3% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-25
Q3 2023 $24.6M $7.92M +$2.94M +58.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $21.6M $6.09M +$1.79M +41.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $19.8M $6.31M +$2.28M +56.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $17.6M $4.26M +$225K +5.58% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-25
Q3 2022 $17.3M $4.99M +$958K +23.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $16.4M $4.3M -$1.18M -21.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $17.6M $4.03M -$346K -7.92% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $17.9M $4.04M +$915K +29.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $17M $4.03M -$463K -10.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $17.5M $5.48M +$514K +10.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $16.9M $4.37M +$383K +9.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $16.6M $3.12M -$502K -13.9% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-09
Q3 2020 $17.1M $4.49M +$576K +14.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $16.5M $4.96M +$940K +23.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $15.5M $3.99M +$701K +21.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $14.8M $3.62M +$632K +21.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-04-13
Q3 2019 $14.2M $3.91M +$1.32M +50.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $12.9M $4.02M +$954K +31.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-17
Q1 2019 $11.9M $3.29M +$652K +24.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $11.3M $2.99M +$1.01M +50.6% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-08
Q3 2018 $10.3M $2.6M +$237K +10% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $10M $3.07M +$808K +35.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $9.24M $2.64M +$808K +44.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $8.43M $1.99M +$514K +34.9% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 $7.92M $2.36M +$877K +59.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $7.04M $2.26M +$648K +40.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $6.39M $1.83M +$468K +34.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $5.93M $1.47M +$534K +56.9% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 $5.39M $1.48M +$351K +31% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $5.04M $1.61M +$494K +44.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $4.55M $1.36M +$457K +50.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $4.09M $938K +$206K +28.1% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $3.88M $1.13M +$326K +40.4% Jul 1, 2015 Sep 30, 2015 10-Q 2017-01-20
Q2 2015 $3.56M $1.12M +$466K +71.5% Apr 1, 2015 Jun 30, 2015 10-Q/A 2017-01-23
Q1 2015 $3.09M $902K +$235K +35.2% Jan 1, 2015 Mar 31, 2015 10-Q/A 2017-01-20
Q4 2014 $2.86M $732K +$79K +12.1% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 $2.78M $806K +$315K +64.2% Jul 1, 2014 Sep 30, 2014 10-Q/A 2017-01-20
Q2 2014 $2.46M $652K +$220K +50.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $2.24M $667K +$330K +97.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $1.91M $653K +$446K +215% Oct 1, 2013 Dec 31, 2013 10-K/A 2017-01-20
Q3 2013 $1.47M $491K +$360K +275% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 $1.11M $432K +$379K +715% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 $728K $337K +$285K +548% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q4 2012 $443K $207K Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 $131K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 $53K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $52K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15

SUPERNUS PHARMACEUTICALS, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $27.8M +$996K +3.72% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-25
2023 $26.8M +$9.19M +52.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-25
2022 $17.6M -$342K -1.91% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-25
2021 $17.9M +$1.35M +8.15% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $16.6M +$1.72M +11.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-09
2019 $14.8M +$3.56M +31.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-04-13
2018 $11.3M +$2.86M +33.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-08
2017 $8.43M +$2.51M +42.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $5.93M +$1.84M +44.9% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $4.09M +$1.23M +43.2% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $2.86M +$944K +49.3% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 $1.91M +$1.47M +332% Jan 1, 2013 Dec 31, 2013 10-K/A 2017-01-20
2012 $443K +$525K Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
2011 -$82K -$379K -128% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-21
2010 $297K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.